Genor Biopharma Holdings Ltd
Genor Biopharma Holdings's GHG Emissions Data Preview
In 2023, Genor Biopharma Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Genor Biopharma Holdings has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Verified Sources Behind Genor Biopharma Holdings’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Genor Biopharma Holdings’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Insights into Genor Biopharma Holdings's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Genor Biopharma Holdings amounted to 2,487.16 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Genor Biopharma Holdings decreased by 59.83%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Genor Biopharma Holdings's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Genor Biopharma Holdings's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Genor Biopharma Holdings were 19.82 metric tons of CO₂ equivalent (tCO₂e). a
Has Genor Biopharma Holdings reduced its Scope 1 emissions over time?
Since 2021, Genor Biopharma Holdings's Scope 1 emissions have decreased by 3.36%, reflecting a declining long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2022), Genor Biopharma Holdings's Scope 1 emissions increased by 10.42%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Genor Biopharma Holdings's Scope 2 emissions?
In 2023, Genor Biopharma Holdings reported Scope 2 greenhouse gas (GHG) emissions of 2,467.34 tCO₂e without specifying the calculation method. a
Has Genor Biopharma Holdings reduced its Scope 2 emissions over time?
Since 2021, Genor Biopharma Holdings's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 68.88%, reflecting a declining long-term trend in Scope 2 emissions over time. a
Compared to the previous year (2022), Genor Biopharma Holdings's Scope 2 emissions (Unspecified Calculation Method) fell by 60.03% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a
What methodology does Genor Biopharma Holdings use for Scope 2 reporting?
In 2023, Genor Biopharma Holdings reported its Scope 2 emissions using an unspecified methodology. a
Genor Biopharma Holdings's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)